ABSTRACT
Bi-potential neuromesodermal progenitors (NMPs) produce both neural and paraxial mesodermal progenitors in the trunk and tail during vertebrate body elongation. We show that Sall4, a pluripotency-related transcription factor gene, has multiple roles in regulating NMPs and their descendants in post-gastrulation mouse embryos. Sall4 deletion using TCre caused body/tail truncation, reminiscent of early depletion of NMPs, suggesting a role of Sall4 in NMP maintenance. This phenotype became significant at the time of the trunk-to-tail transition, suggesting that Sall4 maintenance of NMPs enables tail formation. Sall4 mutants exhibit expanded neural and reduced mesodermal tissues, indicating a role of Sall4 in NMP differentiation balance. Mechanistically, we show that Sall4 promotion of WNT/β-catenin signaling contributes to NMP maintenance and differentiation balance. RNA-Seq and SALL4 ChIP-Seq analyses support the notion that Sall4 regulates both mesodermal and neural development. Furthermore, in the mesodermal compartment, genes regulating presomitic mesoderm differentiation are downregulated in Sall4 mutants. In the neural compartment, we show that differentiation of NMPs towards post-mitotic neuron is accelerated in Sall4 mutants. Our results collectively provide evidence supporting the role of Sall4 in regulating NMPs and their descendants.
INTRODUCTION
The vertebrate embryo develops by progressively adding new tissues at the posterior end of the body after gastrulation. Research in the past decade identified the neuromesodermal progenitors (NMPs), which continue to contribute to both neural tube and somites in post-gastrulation vertebrate embryos (Gouti et al., 2015; Henrique et al., 2015; Kimelman, 2016; Steventon and Martinez Arias, 2017). This finding challenged the conventional view of segregation of three germ layers during gastrulation and impacted on the developmental biology field. NMPs are characterized by the co-expression of the transcription factors SOX2 and T (brachyury, T-box transcription factor T). High levels of expression of Sox2 and T are required for development of the neural lineage and the mesodermal lineage, respectively (Martin and Kimelman, 2012; Olivera-Martinez et al., 2012; Tsakiridis et al., 2014). NMPs express low levels of T and SOX2 and are detected in the node-streak boarder and the caudal lateral epiblast during body elongation (Garriock et al., 2015; Wymeersch et al., 2016). NMPs are later relocated in the chordoneural hinge of the tail bud, where the posterior neural plate overlies the caudal notochord, and continue to contribute to the elongating tail (Aires et al., 2018). In addition, the expression of Nkx1.2 also marks NMPs and other progenitors (Rodrigo Albors et al., 2018). Recent comparison of NMPs in different model systems suggested that NMPs in mouse embryos expand during trunk development and decrease in the tail bud until the embryo terminates tail elongation (Berenguer et al., 2018; Steventon and Martinez Arias, 2017; Wymeersch et al., 2016). Therefore, it is considered that maintenance of NMPs and continued production of neural and paraxial mesoderm (PM) progenitors significantly contribute to the development of the spinal cord and PM-derived tissues in the trunk and tail.
Mouse mutant analyses have provided insights into the maintenance and fate choice of NMPs. Genetic studies show that WNT/β-catenin signaling and T maintain NMPs; embryos with mutations in WNT/β-catenin signaling components or T exhibit severe body truncation due to early depletion of NMPs (Beddington et al., 1992; Cunningham et al., 2015; Galceran et al., 1999; Martin and Kimelman, 2010; Takada et al., 1994). In addition, fibroblast growth factor (FGF) signaling and Cdx genes interact with WNT/β-catenin signaling for NMP maintenance and body elongation (Amin et al., 2016; Diez Del Corral and Morales, 2017). During the fate choice between neural and PM progenitors, defects in the WNT/β-catenin–T regulatory loop cause expansion of neural tissues and reduction of PM, suggesting that WNT/β-catenin signaling promotes NMP differentiation toward the mesodermal lineage (Garriock et al., 2015; Martin and Kimelman, 2012). The WNT/β-catenin–T loop regulates another T-box gene, Tbx6, which functions in early fate choice of NMPs into mesoderm (Javali et al., 2017; Koch et al., 2017; Nowotschin et al., 2012; Takemoto et al., 2011). In contrast, retinoic acid plays a role in promoting differentiation into neural fate (Cunningham et al., 2016; Gouti et al., 2017). Although these reports provide molecular clues to the regulation of NMPs, the molecular mechanisms for NMP maintenance and differentiation are still under active investigation.
After NMPs make the neural versus PM fate decision, those descendants transition to more differentiated cell types within neural and mesodermal compartments, respectively. During neural fate transition, NMPs reach pre-neural tube (PNT) status and express Nkx1.2 and Sox2, and then differentiate into neural progenitors (Gouti et al., 2015; Rodrigo Albors et al., 2018). These cells start to express a specific combination of transcription factors that define distinct progenitor domains in response to patterning signals. For instance, ventral neural progenitors start to express OLIG2, followed by activation of NKX2.2 and subsequently FOXA2 in a more ventral domain, in a mutually exclusive manner. The expression of OLIG2, NKX2.2 and FOXA2 in the ventral neural tube defines progenitor domains for pMN, p3 and floor plate, respectively (Dessaud et al., 2008; Le Dréau and Martí, 2012). The pMN and p3 progenitors further differentiate into the post-mitotic motor neurons and V3 interneurons, respectively. During mesodermal fate transition, NMPs migrate into the presomitic mesoderm (PSM), which involves msgn1 and tbx16 (paralog of mouse Tbx6) in zebrafish (Bouldin et al., 2015; Manning and Kimelman, 2015). In the PSM, Tbx6 and Msgn1 promote PM progenitor differentiation (Chalamalasetty et al., 2014; Javali et al., 2017). As PM cells migrate anteriorly, they become more differentiated under the control of WNT, FGF and NOTCH signaling, in which Hes7 orchestrates oscillatory gene expression patterns to periodically form paired somites (Hubaud and Pourquié, 2014).
Sall4 is a member of the Sall gene family, which encodes zinc finger transcription factors (de Celis and Barrio, 2009; Sweetman and Münsterberg, 2006). Sall4 is highly expressed in pluripotent embryonic stem cells (ESCs) and preimplantation mouse embryos (Elling et al., 2006; Miller et al., 2016; Sakaki-Yumoto et al., 2006). In ESCs, recent studies suggest that Sall4 is a key regulator of the pluripotency transcriptional network and cell cycle progression (Miller et al., 2016; Yuri et al., 2009). In preimplantation mouse embryos, Sall4 is involved in the lineage commitment of inner cell mass cells of the blastocyst to the epiblast and primitive endoderm (Miller et al., 2017 preprint). In post-implantation stages, Sall4 is highly expressed in the epiblast, and Sall4 null embryos die shortly after implantation prior to gastrulation (Elling et al., 2006; Sakaki-Yumoto et al., 2006). In the late gastrulation and post-gastrulation stages, Sall4 is strongly expressed in the caudal part of the body, including the area in which NMPs are detected (Kohlhase et al., 2002; Tahara et al., 2018b). The early lethality of Sall4−/− embryos hampered the investigation of Sall4 functions in post-implantation embryos. We previously reported that Sall4 conditional knockout (cKO) using TCre caused defects in hindlimb development (Akiyama et al., 2015). In this study, we found that TCre; Sall4 cKO neonates exhibit tail truncation, a phenotype observed in mutants with early depletion of NMPs (Beddington et al., 1992; Galceran et al., 1999; Garriock et al., 2015; Herrmann, 1992; Takada et al., 1994). We show that Sall4 is necessary for maintenance of NMPs and neural versus mesodermal differentiation balance of NMPs in post-gastrulation mouse embryos. We further provide genetic evidence that Sall4 plays a role in NMP descendants by regulating differentiation in both mesodermal and neural compartments.
RESULTS
Conditional deletion of Sall4 causes depletion of NMPs and tail truncation
During the analysis of TCre; Sall4 cKO mutants (Akiyama et al., 2015), we found that mutant neonates exhibited tail truncation and disorganized vertebrae, specifically from the posterior thoracic (20th) to the lumbar (26th) vertebrae (Fig. 1A-B″). This suggests developmental defects become significant at E9.0-9.75 (20-28 somite stages). Although we previously confirmed efficient deletion of Sall4 by E8.5 through Sall4 mRNA in situ hybridization (Akiyama et al., 2015), it is possible that the SALL4 protein persists after the mRNA becomes undetectable. Therefore, we examined SALL4 immunoreactivity in the posterior part of the body in whole-mount embryos and sections. We also simultaneously detected T and SOX2 in order to evaluate how SALL4 deletion impacts NMPs.
Sall4 deletion leads to early NMP depletion and body truncation. (A-B″) Lateral (A,B) and dorsal (A′,B′) views of WT and Sall4 cKO neonatal mice stained with Alcian Blue and Alizarin Red. Arrows and arrowheads in A′ and B′ point to the most posterior thoracic and lumber vertebrae, respectively. In the upper-left corner of A′ the edge of the forceps can be seen. A″ and B″ show dorsal views of vertebrae at the thoracic to lumber level. (C-Z′) Whole-mount immunofluorescence images of the caudal part of the body of WT and Sall4 cKO embryos at E8.5 (C-J′), E9.5 (K-R′) and E10.5 (S-Z′). Immunoreactivities for the indicated antibodies are shown. F′,J′,N′,R′,V′,Z′ are magnifications of the boxed areas in F,J,N,R,V,Z, which are shown as overlays of T (green) and SOX2 (magenta) signals. Scale bars: 5 mm (A-B′); 1 mm (A″,B″);100 µm (C-Z).
Sall4 deletion leads to early NMP depletion and body truncation. (A-B″) Lateral (A,B) and dorsal (A′,B′) views of WT and Sall4 cKO neonatal mice stained with Alcian Blue and Alizarin Red. Arrows and arrowheads in A′ and B′ point to the most posterior thoracic and lumber vertebrae, respectively. In the upper-left corner of A′ the edge of the forceps can be seen. A″ and B″ show dorsal views of vertebrae at the thoracic to lumber level. (C-Z′) Whole-mount immunofluorescence images of the caudal part of the body of WT and Sall4 cKO embryos at E8.5 (C-J′), E9.5 (K-R′) and E10.5 (S-Z′). Immunoreactivities for the indicated antibodies are shown. F′,J′,N′,R′,V′,Z′ are magnifications of the boxed areas in F,J,N,R,V,Z, which are shown as overlays of T (green) and SOX2 (magenta) signals. Scale bars: 5 mm (A-B′); 1 mm (A″,B″);100 µm (C-Z).
We found that SALL4 immunoreactivity was reduced, but still detectable in a speckled manner at E8.5 in whole-mount Sall4 mutants, compared with wild-type (WT) controls (n=10; Fig. 1C,G). By section immunofluorescence, SALL4 signals in the mesenchyme were significantly reduced in mutant embryos. SALL4 signals in the epithelial primitive streak, where NMPs are located (Garriock et al., 2015), were detectable, although downregulation was evident (n=3; Fig. S1A). At this stage, approximately 50% of cells in the posterior part of Sall4 mutants lost SALL4 immunoreactivity (Fig. S1B), but WT and Sall4 mutant embryos are morphologically indistinguishable. T+/SOX2+ cells were detected in the caudal lateral epiblast of Sall4 mutants (Fig. 1D-F′,H-J′, Fig. S1A). Quantitative analysis indicated that the ratio of T+/SOX2+ cells was lower in Sall4 mutants than WT (Fig. S1C, Table S1), indicating a reduced NMP population before morphological alterations at E8.5. At E9.5 (20-24 somite stage), SALL4 signals were significantly reduced in the posterior body of Sall4 cKO embryos in whole-mount analysis (n=6; Fig. 1K,O). Section analysis also showed significant reduction of the SALL4 signals in both the posterior neural plate and mesenchymal tissues (n=3; Fig. S1D). Sall4 cKO embryos exhibited a delay of neural tube closure and an enlarged posterior neural plate. T+/SOX2+ cells were reduced in number but still detected in the more medial region compared with WT embryos, possibly owing to the delayed neural tube closure (Fig. 1L-N′,P-R′, Fig. S1D, Table S1). At E10.5, SALL4 signals were undetectable in the mesoderm and were weakly detectable in a speckled manner in the neural tube by whole-mount staining (n=6; Fig. 1S,W). Section analysis confirmed a significant reduction of SALL4 in both neural and mesenchymal tissues (n=3; Fig. S1E). T+/SOX2+ cells were not detected in the tail bud of Sall4 mutants at E10.5, whereas double-positive cells were detected in WT embryos (Fig. 1T-V′,X-Z′, Fig. S1E,F, Table S1). The early depletion of T+/SOX2+ cells in Sall4 mutants compared with WT embryos supports the notion that Sall4 is necessary for NMP maintenance.
These results show a correlation between reduction of SALL4 immunoreactivity and depletion of T+/SOX2+ cells, which further correlates with tail truncation and disorganized vertebrae in Sall4 mutants. These results collectively suggest that Sall4 plays a role in NMP maintenance and body/tail elongation.
Sall4 deletion causes an imbalance between neural versus mesodermal tissues
The enlarged posterior neural plate in Sall4 cKO embryos suggests defects in the balance of differentiation. To assess this possibility, we simultaneously detected SOX2+ neural and LEF1+ mesodermal tissues in the posterior end of the embryo. We used LEF1 instead of T, because T expression is downregulated when mesodermal progenitors further differentiate. We found that the width of the SOX2+ posterior neural plate is enlarged in Sall4 mutants, compared with WT (Fig. 2A,B). Moreover, LEF1+ mesoderm tissue seems to be thinner in Sall4 mutants at E9.5. The reduction of the mesoderm tissue, visualized by T plus LEF1, became more evident in Sall4 mutants at E10.5 (Fig. 2C). Although the increased neural tube width at E9.5 may involve a mechanical failure relating to delayed neural tube closure, these results demonstrate that loss of Sall4 led to increased neural tissue and reduced mesoderm development.
Sall4 deletion causes increased neural tissue and decreased mesodermal tissue. (A) Whole-mount WT and Sall4 cKO embryos at E9.5 stained with antibodies for SOX2 (magenta) and LEF1 (white). (B) Graph of the width of the widest region of the posterior neural plate/tube at E9.5 (shown by double-headed arrows in A, n=3). Shown are mean±s.d. The P-value by unpaired t-test is shown. (C) Whole-mount WT and Sall4 cKO embryos at E10.5 stained with antibodies for T (green) and LEF1 (white). (D-K) Immunofluorescence of LEF1, SOX2, phosphohistone H3 (pHH3) and activated caspase 3 (acCAS3) in the PSM levels of WT (D-G) and Sall4 cKO (H-K) embryos at E10.5. (L) Quantification of LEF1+ nuclei and SOX2+ nuclei in the neural tube without tail gut per total nuclei of the section. (M) Quantification of LEF1+ mesoderm area and SOX2+ neural tube area per all DAPI+ area of the section. (N) Quantification of pHH3+ cells in the mesoderm area and in the neural tube area per total nuclei of the section. (O) Quantification of acCAS3+ cells in the mesoderm area and in the neural tube area per total nuclei of the section. Shown are mean±s.d. P-values are shown in each panel (unpaired t-test). n=4 for both WT and Sall4 cKO. nt, neural tube; psm, presomitic mesoderm; tg, tail gut. Scale bar: 100 µm.
Sall4 deletion causes increased neural tissue and decreased mesodermal tissue. (A) Whole-mount WT and Sall4 cKO embryos at E9.5 stained with antibodies for SOX2 (magenta) and LEF1 (white). (B) Graph of the width of the widest region of the posterior neural plate/tube at E9.5 (shown by double-headed arrows in A, n=3). Shown are mean±s.d. The P-value by unpaired t-test is shown. (C) Whole-mount WT and Sall4 cKO embryos at E10.5 stained with antibodies for T (green) and LEF1 (white). (D-K) Immunofluorescence of LEF1, SOX2, phosphohistone H3 (pHH3) and activated caspase 3 (acCAS3) in the PSM levels of WT (D-G) and Sall4 cKO (H-K) embryos at E10.5. (L) Quantification of LEF1+ nuclei and SOX2+ nuclei in the neural tube without tail gut per total nuclei of the section. (M) Quantification of LEF1+ mesoderm area and SOX2+ neural tube area per all DAPI+ area of the section. (N) Quantification of pHH3+ cells in the mesoderm area and in the neural tube area per total nuclei of the section. (O) Quantification of acCAS3+ cells in the mesoderm area and in the neural tube area per total nuclei of the section. Shown are mean±s.d. P-values are shown in each panel (unpaired t-test). n=4 for both WT and Sall4 cKO. nt, neural tube; psm, presomitic mesoderm; tg, tail gut. Scale bar: 100 µm.
We further evaluated neural and mesodermal tissues in more detail by section immunofluorescence at the level of the PSM. Because of the delayed neural tube closure in Sall4 mutants at E9.5, we sectioned E10.5 embryos at the middle of the PSM. The ratio of LEF1+ mesoderm cells over total DAPI+ cells was reduced in Sall4 mutants, compared with WT (Fig. 2D,H,L). In contrast, the ratio of SOX2+ neural cells was elevated (Fig. 2E,I,L). Similarly, percentage of LEF1+ mesoderm out of the total area was reduced, and the SOX2+ neural area was elevated (Fig. 2M). We also detected a significant reduction of cell proliferation and increased apoptosis in both mesodermal and neural tissues in Sall4 mutants (Fig. 2F,G,J,K,N,O). Therefore, reduced mesodermal cells and increased neural cells are unlikely to be caused by cell type-specific proliferation and/or cell death. Although the T lineage includes other progenitor populations, these results support the notion that the balance between neural versus PM fate choice from NMPs was disrupted in Sall4 mutants.
Sall4 mutants exhibit increased neural and reduced mesodermal molecular programs
Next, we performed transcriptome analysis to characterize molecular changes in Sall4 mutants. We dissected the tissue posterior to the 20th somite levels, where SALL4 was significantly reduced at E9.5, and performed RNA-Seq. The transcriptome showed broad changes of expression of neural and mesodermal genes in Sall4 mutants (Fig. 3A, Figs S2 and S3). With a P-value cutoff of 0.05 and absolute fold change greater than 1.5, we found 98 and 13 dysregulated neuron differentiation (GO:0030182) and mesoderm development (GO:0007498) related genes, respectively. Although Sall4 mutants exhibited reduced mesoderm and expanded neural tube, these genes with neural or mesodermal GO terms included both upregulated and downregulated genes (Figs S2 and S3). Because of the altered neural versus mesodermal balance in Sall4 cKO embryos, we tested the hypothesis that the dysregulated genes in Sall4 mutants are significantly associated with the mesoderm and neural differentiation/development functions. We performed Gene Set Enrichment Analysis (GSEA) (Subramanian et al., 2005) using 107 known genes related to mesoderm development (GO:0007498). We also performed GSEA using 500 known genes randomly chosen from the 1378 neuron differentiation genes (GO:0030182). The reported GSEA P-values for neuron differentiation and mesoderm development were both <0.001 (Fig. 3B,C), which indicated that the mesoderm development and neuron differentiation functions are significantly enriched in the differentially expressed genes. We additionally performed Fisher's exact test by using all the 1378 genes with the neuron GO term, which also showed a significant increase in the number of differentially expressed neural genes in Sall4 mutants (P=2.945e-07). These results are consistent with the immunofluorescence data and support the notion that mesodermal and neural differentiation are impaired in Sall4 mutants.
Sall4 deletion causes changes of expression of genes related to NMP maintenance and neural and mesodermal genes. (A) Heat map of genes with GO term as neural genes (upper) and mesoderm genes (lower) in WT versus Sall4 cKO. (B,C) GSEA analysis of genes with GO terms of neural differentiation (B) and mesoderm development (C) among genes that are differentially expressed in WT versus Sall4 cKO posterior tissue. (D-Q) Whole-mount in situ hybridization of the indicated genes in WT (D-J) and Sall4 cKO (K-Q) at E9.5. Black arrowheads point to normal expression in the posterior tip of the body in WT embryos and Sox2 and Cyp26a1 expression in the Sall4 cKO embryo. Blue arrowheads point to reduced expression in Sall4 cKO embryos (K,M-P). Red arrowhead in L points to upregulated Sox2 expression in the Sall4 cKO embryo.
Sall4 deletion causes changes of expression of genes related to NMP maintenance and neural and mesodermal genes. (A) Heat map of genes with GO term as neural genes (upper) and mesoderm genes (lower) in WT versus Sall4 cKO. (B,C) GSEA analysis of genes with GO terms of neural differentiation (B) and mesoderm development (C) among genes that are differentially expressed in WT versus Sall4 cKO posterior tissue. (D-Q) Whole-mount in situ hybridization of the indicated genes in WT (D-J) and Sall4 cKO (K-Q) at E9.5. Black arrowheads point to normal expression in the posterior tip of the body in WT embryos and Sox2 and Cyp26a1 expression in the Sall4 cKO embryo. Blue arrowheads point to reduced expression in Sall4 cKO embryos (K,M-P). Red arrowhead in L points to upregulated Sox2 expression in the Sall4 cKO embryo.
Correlating with the tail truncation in Sall4 mutant neonates, genes that are known to regulate NMPs and body elongation are consistently downregulated in the transcriptome (Fig. 3A). Consistent with our immunofluorescence analysis (Fig. 1, Fig. S1), we detected reduced expression of T and higher expression of Sox2 by whole-mount in situ hybridization (Fig. 3D,E,K,L). Strong Sox2 expression extended further into the posterior edge of the neural plate in Sall4 cKO embryos, compared with WT. Expression of Fgf8 and Wnt3a, necessary for NMP maintenance and body elongation (Henrique et al., 2015), were downregulated (Fig. 3F,H,M,O). Expression of Dusp6 and Axin2, targets of FGF signaling and WNT signaling, respectively, were also downregulated (Fig. 3G,I,N,P). In contrast, the expression pattern of Cyp26a1, which is required to degrade retinoic acid in the posterior part of the body (Abu-Abed et al., 2001; Sakai et al., 2001), did not exhibit significant reduction (Fig. 3J,Q). At E10.5, the reduction of expression of these genes, including Cyp26a1, became more significant (Fig. S4). These changes of expression pattern support the idea that loss of Sall4 causes defects in the WNT-T-FGF regulatory system, which subsequently causes downregulation of Cyp26a1.
Given the known roles of WNT/β-catenin signaling in NMPs (Gouti et al., 2015; Henrique et al., 2015; Kimelman, 2016), we further characterized activation of WNT/β-catenin signaling in more detail by immunofluorescence. We simultaneously stained whole-mount E9.5 embryos with antibodies against T, SOX2 and active β-catenin (Fig. 4A-D). The fluorescent images show that Sall4 mutants exhibited reduced levels of nuclear β-catenin, compared with WT. Furthermore, analysis of β-catenin signal intensity in each cell also supported the notion that nuclear β-catenin levels are reduced in Sall4 mutants (Fig. S5). By using nuclear DAPI signals in every layer of images, we confirmed the presence or absence of T, SOX2 and nuclear active β-catenin signals, and constructed a map of cell distribution of each marker combination (Fig. 4B,D,E). The map showed an increased distribution of cells without nuclear active β-catenin, indicating reduced WNT/β-catenin signaling in Sall4 mutants. Within each of the three populations of T- and/or SOX2-positive cells, the ratio of nuclear active β-catenin+ cells was reduced in Sall4 mutants (Table 1). These analyses support the idea that reduction of WNT/β-catenin signaling is a mechanism for the defects in NMPs in Sall4 mutants.
Downregulation of WNT/β-catenin signaling in Sall4 cKO embryos. (A,C) Stacked confocal images of whole-mount-stained WT and Sall4 cKO embryos at E9.5. (A′,A″,C′,C″) Single-layer images of embryos stained for T (green), SOX2 (magenta) and active β-catenin. Shown are high magnifications of single-layer images in the areas indicated in A or C. (B,D) Stacked maps of cells with different combinations of T, SOX2 and active β-catenin with the color code shown in E. (E) Quantification of cells with different combinations of T, SOX2 and active β-catenin (as shown in B and D). n=4 for WT, n=3 for Sall4 cKO. Scale bars: 100 µm (A,C); 10 µm (A′,A″,C′,C″).
Downregulation of WNT/β-catenin signaling in Sall4 cKO embryos. (A,C) Stacked confocal images of whole-mount-stained WT and Sall4 cKO embryos at E9.5. (A′,A″,C′,C″) Single-layer images of embryos stained for T (green), SOX2 (magenta) and active β-catenin. Shown are high magnifications of single-layer images in the areas indicated in A or C. (B,D) Stacked maps of cells with different combinations of T, SOX2 and active β-catenin with the color code shown in E. (E) Quantification of cells with different combinations of T, SOX2 and active β-catenin (as shown in B and D). n=4 for WT, n=3 for Sall4 cKO. Scale bars: 100 µm (A,C); 10 µm (A′,A″,C′,C″).
SALL4-binding sites are enriched in neural and mesodermal genes
In order to further gain insights into Sall4 functions, we performed SALL4 ChIP-Seq experiments. Because vertebrate defects in Sall4 cKO neonates are likely derived from defects in PM, we collected tissues posterior to the PSM/somite boundary at E9.5 (Fig. 5A). This tissue included the caudal progenitor zone and PSM but excluded the neural tissue (hereafter referred to as the posterior tissue). We first compared SALL4-enriched sequences in the posterior tissues and in ESCs (Miller et al., 2016). Among 35,756 sequences bound by SALL4 in the posterior tissues, only 4.2% was also bound by SALL4 in ESCs, indicating significantly different binding sites in two cell/tissue types (Fig. 5B). Next, we analyzed locations of SALL4-bound sequences, in which we defined promoter regions as sequences within 10 kb upstream from the transcription start site. Although SALL4 binding to intergenic sequences (46.6%) and introns (26.8%) is significant in the posterior tissues, enrichment in these sites was less frequent than in ESCs (53.5% and 40.2% of bound sequences in intergenic and introns, respectively). Instead, SALL4 binding to the promoters, 5′UTRs and exons was noticeably higher in the posterior tissue than SALL4 binding to such sites in ESCs. The Binomial test suggested that the proportion of SALL4 ChIP-Seq peaks located in transcription start site/promoter/5′UTR regions in the posterior tissues was significantly higher than in ESCs (20.4% versus 3.49%, P<2.2e-16) (Fig. 5C). The distribution of peaks that are bound by SALL4 in both the posterior tissue and mESCs was more similar to the peak distribution in posterior tissue than to that in mESCs. The top-enriched motifs of SALL4-bound sequences in the posterior tissue included motifs for ETS, androgen receptor, YY2 zinc finger factor and ZBTB3 (Fig. S6). These motifs are in contrast to top-enriched motifs in mESCs, such as motifs of OCT4 (POU5F1), ESRRB, KLF and SOX (Fig. S6) (Miller et al., 2016). The difference of motifs indicates that Sall4 function is cell/tissue-context dependent.
SALL4 ChIP-Seq analysis of the posterior tissue and downregulation of mesoderm differentiation genes in Sall4 cKO embryos. (A) Schematic of dissected posterior tissue (blue) for SALL4 ChIP-Seq analysis. (B) Venn diagram for SALL4-enriched sequence numbers in the posterior tissue and mESCs. (C) Distributions of SALL4-enriched sequences in the posterior tissue, mESCs and both cell/tissue types. (D,E) GSEA analysis of genes with GO terms of neural differentiation (D) and mesoderm development (E) among genes that are enriched by SALL4 in the posterior tissue. (F-K) Whole-mount in situ hybridization of the indicated mesodermal genes in WT and Sall4 cKO embryos at E9.5. Black arrowheads point to normal expression in WT PSM (F-H). Blue arrowheads point to reduced expression in the PSM in Sall4 cKO embryos (I-K). (L-N) Visual representation of SALL4 ChIP-Seq results of the indicated gene loci. Post., the posterior tissue.
SALL4 ChIP-Seq analysis of the posterior tissue and downregulation of mesoderm differentiation genes in Sall4 cKO embryos. (A) Schematic of dissected posterior tissue (blue) for SALL4 ChIP-Seq analysis. (B) Venn diagram for SALL4-enriched sequence numbers in the posterior tissue and mESCs. (C) Distributions of SALL4-enriched sequences in the posterior tissue, mESCs and both cell/tissue types. (D,E) GSEA analysis of genes with GO terms of neural differentiation (D) and mesoderm development (E) among genes that are enriched by SALL4 in the posterior tissue. (F-K) Whole-mount in situ hybridization of the indicated mesodermal genes in WT and Sall4 cKO embryos at E9.5. Black arrowheads point to normal expression in WT PSM (F-H). Blue arrowheads point to reduced expression in the PSM in Sall4 cKO embryos (I-K). (L-N) Visual representation of SALL4 ChIP-Seq results of the indicated gene loci. Post., the posterior tissue.
A significant fraction of SALL4-bound sequences in the posterior tissue can be directly assigned to specific genes based on binding to promoters (17.1%), 5′UTRs (3.3%), exons (7.2%) or introns (26.8%). We tested whether SALL4 binding is enriched in genes with mesodermal or neural GO terms by GSEA. Out of 109 genes with mesodermal GO, 95 genes are enriched by SALL4. For genes with neural GO, out of the 500 randomly selected genes, 367 genes were enriched by SALL4. The GSEA indicated that genes with mesoderm development and neuron differentiation functions are significantly enriched in the genes that have SALL4 ChIP-Seq peaks (Fig. 5D,E). Although the posterior tissue used in the ChIP-Seq experiments is not homogeneous, the caudal progenitor zone is also enriched in the posterior tissue, in addition to the PSM. Accordingly, we found SALL4 enrichment in some genes that are known to regulate NMPs (Table S2). These genes include Cdx2, T and Sox2. In summary, the results of ChIP-Seq and RNA-Seq together support the idea that SALL4 regulates NMPs as well as mesodermal and neural differentiation of NMP descendants.
Sall4 regulates nascent mesoderm differentiation
Posterior axial skeletal defects in Sall4 cKO neonates suggest that loss of Sall4 caused mesodermal differentiation defects in PSM. Consistent with this idea, the expression pattern of Msgn1, a master regulator of PSM differentiation (Chalamalasetty et al., 2014; Yoon and Wold, 2000), was severely downregulated (Fig. 5F,I). Wnt5a, which is required for outgrowth of the tail (Yamaguchi et al., 1999), was downregulated in the PSM, but not in the posterior neural plate (Fig. 5G,J). Hes7, which regulates oscillation of gene expression in the PSM (Bessho et al., 2001), was also downregulated (Fig. 5H,K). These genes are bound by SALL4 (Fig. 5L-N), which is consistent with the GSEA data and suggests a direct regulation of these genes by SALL4. These data support the role of Sall4 in promoting mesodermal differentiation in the PSM.
Loss of Sall4 causes accelerated neural differentiation
Next, we asked whether loss of Sall4 by TCre also affects differentiation within the neural compartment. The expression of Nkx1.2, a marker for NMPs and PNT cells, was detected in the posterior end of the neural plate and its immediate anterior region of the neural tube of WT embryos (Fig. 6A). In Sall4 mutants, Nkx1.2 was expressed in the expanded posterior end of the neural plate, but its expression in the posterior neural tube was undetectable (Fig. 6A,E). Similarly, expression of Sox2, a marker for NMPs, PNT cells and neural progenitor cells, was extended into the posterior end of the neural plate in Sall4 mutants (Fig. 3E,L). Given the reduction of T+/SOX2+ NMP number in Sall4 mutants, the expression pattern of Nkx1.2 and Sox2 implies that more PNT cells are present in the posterior neural plate but they are absent in the posterior neural tube in Sall4 mutants. Weak expression of Sox1, a neural progenitor marker, was detected in the posterior end of the neural plate of Sall4 mutants at both mRNA and protein levels, which was not detected in WT embryos (Fig. 6B,C,F,G). These results support the idea that differentiation of NMPs to neural progenitors through the PNT status is accelerated in Sall4 mutants.
Accelerated neural patterning and differentiation in the posterior region of Sall4 cKO embryos. (A,B,E,F) In situ hybridization of Nkx1.2 and Sox1 at E9.5 in WT (A,B) and Sall4 cKO (E,F) embryos. Black arrowhead and arrow in A point to expression in the posterior neural plate and the posterior neural tube, respectively. Red arrowheads point to increased (E) or ectopic (F) expression. Asterisks mark lack of expression. Bracket indicates Sox1 expression in the neural tube. (C,G) Confocal images of SOX1 expression in the posterior of whole-mount embryos. Dashed lines indicate posterior end of the neural plate. Red arrowhead points to ectopic expression of SOX1 (G). Asterisk indicates a lack of SOX1 signals at the posterior end of the neural plate (C). (D,H) Immunofluorescence of OLIG2 (magenta) and NKX2.2 (green) in WT (D) and Sall4 cKO (H) embryos at E9.75 (27/28 somite stage). Red arrowhead points to NKX2.2+ cells in Sall4 cKO embryos. Dotted circle indicates the notochord (n). (I) Quantification of NKX2.2+ cells at the posterior hindlimb level at E9.75. Graphs shows numbers of cells (mean±s.d.) per section. P-values by unpaired t-test are shown. n=5 for WT, n=6 for Sall4 cKO. (J-Q) Immunofluorescence of the indicated markers in WT (J-M) and Sall4 cKO (N-Q) embryos at E10.25 (33/34 somite stage). White and red arrowheads point to ISL1+ cells at the posterior hindlimb level in WT (M) and Sall4 cKO (Q) embryos, respectively. In K and O, DBX1 signals are shown in white. (R,S) Quantification of ISL1+ cells (R) and FOXA2+ cells (S) at the posterior hindlimb level at E10.25. Graphs show numbers of cells (mean±s.d.) per section. P-values by unpaired t-test are shown within each panel. n=5 for both WT and Sall4 cKO. Scale bars: 100 µm (C,G); 50 µm (D,H,J-Q).
Accelerated neural patterning and differentiation in the posterior region of Sall4 cKO embryos. (A,B,E,F) In situ hybridization of Nkx1.2 and Sox1 at E9.5 in WT (A,B) and Sall4 cKO (E,F) embryos. Black arrowhead and arrow in A point to expression in the posterior neural plate and the posterior neural tube, respectively. Red arrowheads point to increased (E) or ectopic (F) expression. Asterisks mark lack of expression. Bracket indicates Sox1 expression in the neural tube. (C,G) Confocal images of SOX1 expression in the posterior of whole-mount embryos. Dashed lines indicate posterior end of the neural plate. Red arrowhead points to ectopic expression of SOX1 (G). Asterisk indicates a lack of SOX1 signals at the posterior end of the neural plate (C). (D,H) Immunofluorescence of OLIG2 (magenta) and NKX2.2 (green) in WT (D) and Sall4 cKO (H) embryos at E9.75 (27/28 somite stage). Red arrowhead points to NKX2.2+ cells in Sall4 cKO embryos. Dotted circle indicates the notochord (n). (I) Quantification of NKX2.2+ cells at the posterior hindlimb level at E9.75. Graphs shows numbers of cells (mean±s.d.) per section. P-values by unpaired t-test are shown. n=5 for WT, n=6 for Sall4 cKO. (J-Q) Immunofluorescence of the indicated markers in WT (J-M) and Sall4 cKO (N-Q) embryos at E10.25 (33/34 somite stage). White and red arrowheads point to ISL1+ cells at the posterior hindlimb level in WT (M) and Sall4 cKO (Q) embryos, respectively. In K and O, DBX1 signals are shown in white. (R,S) Quantification of ISL1+ cells (R) and FOXA2+ cells (S) at the posterior hindlimb level at E10.25. Graphs show numbers of cells (mean±s.d.) per section. P-values by unpaired t-test are shown within each panel. n=5 for both WT and Sall4 cKO. Scale bars: 100 µm (C,G); 50 µm (D,H,J-Q).
We next asked whether differentiation of neural progenitors is also affected in Sall4 mutants. Neural progenitors in the ventral neural tube express OLIG2, followed by NKX2.2 and then FOXA2, in a progressively ventrally localized manner. The onset of their expression correlates with the progression of neural progenitor differentiation (Dessaud et al., 2008, 2007). We examined the expression pattern of these markers to assess neural differentiation status by using somite number-matched embryos for careful comparison of WT and Sall4 mutants. Furthermore, we used outgrowth of hindlimb buds and expression of PLZF (ZBTB16) in the hindlimb mesenchyme (Akiyama et al., 2015) in adjacent sections in order to identify sections representing posterior hindlimb levels (Fig. S7). At E9.75 (27/28 somite stage), OLIG2 is expressed in the ventral neural tube, whereas NKX2.2 is undetectable at the posterior hindlimb level in WT (Fig. 6D). In contrast, NKX2.2 is expressed in the ventral-most neural tube between the two dorsally positioned OLIG2 domains (Fig. 6H,I), indicating precocious neural differentiation in Sall4 mutants. At E10.25 (33/34 somite stage), the p3, pMN and p0 domains express NKX2.2, OLIG2 and DBX1, respectively, in a ventral-to-dorsal order in both WT and Sall4 mutants (Fig. 6J,K,N,O). NKX6.1, which marks ventral progenitors, and PAX6, which marks an intermediate region, did not show changes of their domain (Fig. 6K,L,O,P, Fig. S8). These expression patterns suggest that the gross patterning of neural tube along the dorsoventral axis is not altered in Sall4 mutants. At the same stage, we found that Sall4 mutants exhibited a significantly greater number of ISL1-expressing cells at the hindlimb level, compared with WT embryos (Fig. 6M,Q,R). As Isl1 is an essential gene for post-mitotic motor neuron identity (Dessaud et al., 2008), this result indicates precocious appearance of motor neurons in Sall4 mutants. These results suggest that the progression of neural patterning and differentiation is accelerated in Sall4 mutants. Examination of FOXA2-expressing floor plate cell numbers showed no significant differences between WT and Sall4 cKO embryos at the hindlimb level (Fig. 6M,Q,S), suggesting that the increased number of ISL1-expressing cells is unlikely to be caused by increased floor plate cells, which produce the ventral morphogen sonic hedgehog. Unlike the hindlimb, numbers of ISL-expressing cells at the forelimb level were slightly lower in Sall4 mutants than in WT embryos (Fig. S9), at which level Sall4 mutants do not exhibit significant defects (Fig. 1A,B). These results support the idea that differentiation of NMP descendants in the neural compartment is promoted in Sall4 mutants.
DISCUSSION
We propose a model whereby Sall4 plays multiple roles in the posterior part of the embryo (Fig. 7). Sall4 participates in the maintenance of and neural versus mesodermal differentiation balance of NMPs. Sall4 might also be involved in the transition of NMPs from the trunk to the tail bud during body elongation. In addition, Sall4 promotes mesodermal differentiation and restricts neural differentiation of NMP descendants. Involvement of Sall4 in the regulation of multiple processes in developing embryos complicates the analyses of Sall4 function. Several studies have developed protocols for an in vitro derivation of NMP-like cells and their differentiation from pluripotent stem cells (Gouti et al., 2014; Lippmann et al., 2015; Tsakiridis et al., 2014; Turner et al., 2014). Such an in vitro approach will help further dissect roles of Sall4 in multiple steps of regulation of NMPs and their descendants in vitro.
A model of Sall4 function in NMPs and their descendants in the mouse embryo. Proposed functions of Sall4 for NMP maintenance and regulation of differentiation between mesodermal versus neural fate, promotion of mesodermal differentiation and restriction of neural differentiation of NMP descendants. For more detail see Discussion.
A model of Sall4 function in NMPs and their descendants in the mouse embryo. Proposed functions of Sall4 for NMP maintenance and regulation of differentiation between mesodermal versus neural fate, promotion of mesodermal differentiation and restriction of neural differentiation of NMP descendants. For more detail see Discussion.
Mouse mutants with defects in WNT/β-catenin signaling show severe body truncation posterior to the forelimb bud level due to early depletion of NMPs (Galceran et al., 1999; Takada et al., 1994). The axial levels of defects in these mutants are consistent with the observation that NMPs contribute to tissues posterior to the 6th somite level (forelimbs develop at 7-12 somite levels) (Henrique et al., 2015; Tzouanacou et al., 2009). In contrast, TCre; Sall4 mutants exhibited truncation at the tail level. This difference would involve SALL4 protein that has been produced before TCre-mediated disruption of the Sall4 gene, compared with null alleles used in other studies. Sall4 is highly expressed in the epiblast at early post-implantation stages before TCre-mediated recombination (Sakaki-Yumoto et al., 2006). The pre-existing SALL4 protein might be stable and persist after Sall4 gene abrogation, which is consistent with our immunofluorescence analysis of Sall4 cKO embryos. The timing of significant SALL4 depletion in Sall4 mutants allowed us to investigate Sall4 function separated from gastrulation. Therefore, even though the truncation defects of Sall4 mutants are milder than those observed in other mutants, our data support the role of Sall4 in NMP maintenance and body/tail elongation in vivo.
The tail truncation of Sall4 mutants also suggests a possibility that Sall4 regulates transition of NMPs from the trunk to the tail. A lineage-tracing experiment indicated that NMPs are a continuous cell population that contributes to the trunk and tail (Tzouanacou et al., 2009). Recent studies indicated that Gdf11-dependent transition of NMPs from the trunk into the tail bud is required for tail elongation (Jurberg et al., 2013). This transition occurs around E9.5, which correlates with the timing at which Sall4 cKO embryos exhibit defects in the posterior of the body (Aires et al., 2018). Tail elongation involves distinct mechanisms from the trunk, such as the Gdf11-Lin28-Hox13 system (Aires et al., 2019; Aires et al., 2016; Robinton et al., 2019). Therefore, it is also possible that Sall4 regulates the NMP transition into the tail bud and tail-specific elongation mechanisms. This possibility does not rule out the possibility that Sall4 directly regulates NMPs. Further analysis with cell type-specific and fine-temporal dissection of function of Sall4 would enhance our understanding of NMP biology and trunk-tail elongation.
Our study suggests that Sall4 promotion of WNT/β-catenin signaling is a mechanism for Sall4 regulation of NMPs. Previous studies showed that SALL4 can interact with β-catenin when transfected in vitro and can enhance WNT/β-catenin signaling in luciferase reporter assays (Hobbs et al., 2012). In addition, Sall4 and Ctnnb1 genetically interact to regulate anterior-posterior axis formation in mouse embryos (Uez et al., 2008). Consistent with these reports, we observed reduction of WNT/β-catenin signaling in the posterior part of Sall4 cKO embryos. It has been shown that WNT/β-catenin signaling is essential for NMP maintenance (Gouti et al., 2015; Henrique et al., 2015; Kimelman, 2016), and NMP differentiation into mesodermal lineages (Garriock et al., 2015; Martin and Kimelman, 2012), and acts upstream of Tbx6 to regulate PSM differentiation (Dunty et al., 2008). Therefore, Sall4 promotion of WNT/β-catenin signaling could act as a mechanism for these functions. The TCre; Sall4 mutants exhibited an expanded neural tube, but not the formation of a supernumerary neural tube observed in Wnt3a−/− mutants (Garriock et al., 2015). Owing to the use of the conditional inactivation strategy and SALL4 stability discussed above, SALL4 protein depletes gradually in TCre; Sall4 mutants from E8.5 to E10.5. Residual SALL4 may be responsible for gradual downregulation of β-catenin signaling rather than abolishment, which could have caused the difference of an ectopic neural tube formation. It should be noted that the precise mechanisms by which Sall4 regulates WNT/β-catenin signaling in the posterior body remain to be determined. The SALL4 enrichment near Cdx2, T and Sox2 observed in our ChIP-Seq experiment also suggests that Sall4 may directly regulate these genes for NMP maintenance. In addition, Sall4 may genetically interact with Cdx genes to regulate NMPs, as a sall4-cdx4 interaction is reported to regulate hematopoiesis in the lateral plate mesoderm in zebrafish (Paik et al., 2013). Further study will help fully understand how Sall4 regulates NMPs and their descendants. In the case of mesodermal differentiation, our ChIP-Seq data suggest that SALL4 also directly regulates some genes in the PM, including Msgn1. A previous study demonstrated that Msgn1 is a target of WNT/β-catenin signaling (Chalamalasetty et al., 2011), and Sall4 might also promote Msgn1 expression through WNT/β-catenin signaling. Thus, the defects in the mesodermal tissue in Sall4 mutants could be mediated, in part, by reduced Msgn1 expression. However, Msgn1−/− embryos exhibit an expanded T expression domain, opposite to what we observed in Sall4 mutants (Chalamalasetty et al., 2014; Yoon and Wold, 2000). This difference suggests that Msgn1 also functions in parallel with Sall4, as a master regulator of PM development.
In mESCs, SALL4 inhibits neural differentiation (Miller et al., 2016). In the posterior tissue, Sall4 also restricts neural differentiation, which is observed as precocious neural patterning and differentiation in Sall4 mutants. However, SALL4-bound sequences are significantly different in ESCs and the posterior tissue, suggesting that mechanisms of Sall4 regulation of neural differentiation are different in ESCs and the posterior tissue. One explanation for this difference is the possibility that SALL4 acts with other cell type-specific transcription factors. In this scenario, SALL4 regulates different downstream genes depending on its partners. Another possible mechanism is direct regulation of neural differentiation genes by SALL4 in the posterior tissues, which is supported by significant enrichment of SALL4 targets in the neural differentiation GO.
It has been noted that some cell types in the trunk, such as spinal cells and skeletal muscle, are difficult to generate from pluripotent stem cells in vitro (Gouti et al., 2014). Recent progress in the derivation and directed differentiation of NMPs from pluripotent stem cells strongly suggested that anterior neural plate and posterior trunk neurons have distinct developmental origins (Henrique et al., 2015). According to this idea, NMPs contribute to trunk neurons, such as spinal motor neurons, during body/tail elongation. Generation and characterization of trunk neural cell types through NMPs is a topic of wide interest with the potential for therapeutic application (Gouti et al., 2015; Verrier et al., 2018). Recent reports demonstrated that manipulation of retinoic acid, hedgehog and BMP/TGFβ signaling can alter neural differentiation from NMPs (Cunningham et al., 2016; Gouti et al., 2014; Lippmann et al., 2015; Verrier et al., 2018). Therefore, accelerated neural patterning and differentiation in the absence of Sall4 in NMPs and their descendants offer a possibility of manipulating neural differentiation in vitro through regulating functions of Sall4 in combination with these signaling pathways.
MATERIALS AND METHODS
Animal breeding, skeletal preparation and in situ hybridization
Embryos were collected by timed mating of Sall4fl/fl females and TCreTg/Tg; Sall4+/fl males (Akiyama et al., 2015). Alcian Blue/Alizarin Red skeletal staining and whole-mount in situ hybridization were performed as previously described (Akiyama et al., 2015). Three to five embryos per probe per stage were examined by whole-mount in situ hybridization. Animal breeding was performed according to approval of the Institutional Animal Care and Use Committee of the University of Minnesota.
Immunofluorescence
For whole-mount staining, embryos were fixed in 4% paraformaldehyde (PFA) at 4°C for 2 h, then washed with PBS+0.1% Triton X-100 (PBSTr), blocked with 5% donkey serum in PBSTr for 60 min at room temperature, and stained and rocked overnight with primary antibodies at 4°C. After washing with PBSTr, embryos were stained with secondary antibodies at 4°C overnight, washed, and incubated with DAPI solution. For section staining, cryosections of 14 µm thickness were treated as previously described (Akiyama et al., 2015; Tahara et al., 2018a). Antibodies and working dilutions are listed in Table S3. Images were acquired using a Zeiss LSM710 confocal microscope with Zen software.
Quantification of neural versus mesodermal differentiation
For analysis of neural versus mesodermal tissues (shown in Fig. 2), E10.5 embryos were cryosectioned at the PSM level and stained with anti-SOX2 and anti-LEF1. We acquired three section images at the middle of the PSM from each embryo, and the average cell count or area measurement was used as representative data of each embryo. The total number of cells, LEF1+ cells, SOX2+ cells, pHis3+ cells and activated caspase 3+ cells were counted using ImageJ. WT (n=4) and Sall4 cKO (n=4) embryos were analyzed, and significance was determined by unpaired t-test.
Quantification of T, SOX2 and active β-catenin signals from whole-mount samples
After whole-mount staining, embryos were mounted on glass-bottom dishes using low melting agarose. Fluorescent images were acquired every 1 µm along the z-axis until we obtained the widest part of the embryos (15-20 images/embryo). We evaluated whether each of DAPI+ nucleus possessed overlapping signals of T, SOX2 and/or active β-catenin using Photoshop, and constructed a map of each layer. The final map was generated by overlaying all maps.
Quantification of markers in the neural tube
Using PLZF signals and hindlimb bud morphologies of adjacent sections, we chose two sections from each embryo, which represented the levels of the posterior part of the hindlimbs. Cells with FOXA2+, ISL1+, NKX2.2+ or OLIG2+ signals were counted using ImageJ. The average cell count of two sections was used as representative data of each embryo. Five embryos (both WT and Sall4 cKO) were analyzed for each graph, and significance was determined by unpaired t-test.
RNA-Seq and ChIP-Seq
Tissues posterior to somite level 20 were collected from E9.5 embryos and total RNA was purified using the RNeasy micro kit (Qiagen). Strand-specific RNA-Seq libraries were created using the Illumina Library Creation System with 0.5 µg of RNA. Sequencing (50 base paired end, v4 chemistry, 20 million reads per sample) was performed with HiSeq2500 at the University of Minnesota Genomic Center. Data were analyzed by TopHat and Bowtie (Trapnell et al., 2012).
For ChIP-Seq, tissues posterior to the boundary of the PSM and the somite were collected from E9.5 WT embryos. Tissues were kept in PBS on ice during dissection, and treated with dispase (1.5 mg/ml, Roche, 4942078001, 37°C, 5 min), followed by removal of the neural tube in cold PBS. The remaining tissue (the posterior tissue) was dissociated using TrypLE (Invitrogen) at 37°C for 5 min, neutralized with DMEM+10% fetal bovine serum, and collected by low speed centrifugation. Approximately 100 embryos were used per sample. Cells were treated following a previously published procedure (Kanda et al., 2014; Park et al., 2012). Cells were fixed with 1% PFA in Crosslinking buffer (100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 50 mM HEPES) for 5 min at room temperature. The reaction was stopped by adding 1/10 volume of 1.25 M glycine on ice for 5 min. Cells were collected by low speed centrifugation, and stored at −80°C until a sufficient amount of cells (1.0×107 per sample) were collected. Cells were subjected to sonication using the truChip Chromatin Shearing Reagent kit (Covaris, PN 520154) with a Covaris S220 (peak power: 105 W; duty factor: 2%; cycles/burst: 200; water temperature: 4°C; total processing time: 5 min). Dynabeads (50 µl, Thermo Fisher, 10003D) were coupled with the 10 µg of anti-SALL4 antibody (Abcam, ab29112) for 30 min at room temperature, and incubated with sheared chromatin overnight at 4°C. The Dynabeads were washed with washing buffer (50 mM HEPES, pH7.5, 0.5 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA) six times. The immunoprecipitated complexes were eluted and reverse-crosslinked from the beads by adding elution buffer (50 mM Tris-HCl, pH 8, 1% SDS, 10 mM EDTA) and heating at 65°C overnight. Immunoprecipitated DNA was treated with RNase A and proteinase K, and purified for library synthesis. The sequencing was performed using HiSeq2500 (50 base paired end, 20 million reads per sample). The sequencing data were analyzed with MACS2 (Zhang et al., 2008).
Acknowledgements
We are grateful to Jennifer Kim and Samantha Young for their excellent technical assistance. We are also grateful to Drs Juan Carlos Izpisúa Belmonte, David Lohnes, Michael O'Connor, Virginia Papaioannou and Terry Yamaguchi for sharing materials and/or equipment.
Footnotes
Author contributions
Conceptualization: Y.K.; Formal analysis: N.T., K.C., W.G., P.S., Y.N., Y.K.; Investigation: N.T., H.K., K.Q.C., A.A., M.Y.P., W.G., P.S., S.H., Y.K.; Resources: R.N., Y.N., D.J.G., Y.K.; Writing - original draft: K.Q.C., Y.K.; Writing - review & editing: N.T., H.K., K.Q.C., A.A., M.Y.P., W.G., P.S., S.H., R.N., Y.N., D.J.G., Y.K.; Visualization: Y.K.; Supervision: Y.N., D.J.G., Y.K.; Project administration: Y.K.; Funding acquisition: Y.K.
Funding
This study was supported by grants from the National Institutes of Health (R01AR064195 to Y.K.; R01HL122576 to D.J.G.). Deposited in PMC for release after 12 months.
Data availability
RNA-Seq and ChIP-Seq data have been deposited in the Sequence Read Archive database under BioProject accession number PRJNA525663.
References
Competing interests
The authors declare no competing or financial interests.